ADARx Pharmaceuticals, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ADRX Nasdaq 2836 www.adarx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ADARx Pharmaceuticals, Inc.

ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering - Oct 1st, 2026 2:15 pm
ADARx Pharmaceuticals (ADRX) Moved Higher, But What Is Drawing Attention? - Sep 27th, 2026 9:10 pm
ADARx Pharmaceuticals Announces Pricing of Upsized $446.3 Million Initial Public Offering - Sep 24th, 2026 5:33 pm